Freire Maria C — SEC Form 4 filings
SEC reporting owner CIK 1547999. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-17 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 72,998 shares, $2,709,627 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 44,114 shares @ $34.94 ($1,541,343) in EXELIXIS, INC., filed 2025-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EXELIXIS, INC. (EXEL) | Director | 6 | — | 3 legs · 72,998 sh · $2,709,627 | 9 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Director | 3 | — | — | 3 |
| BIOGEN INC. (BIIB) | Director | 3 | — | — | 3 |
Form 4 filings — Freire Maria C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 2,005 @ $0 | EDGAR |
| 2026-05-29 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 8,367 @ $0 | EDGAR |
| 2026-05-08 | 4 | EXELIXIS, INC. (EXEL) | Option exercise (M): 20,634 @ $19.77 · Sale (S): 20,634 @ $46 · Option exercise (M): 20,634 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 3,493 @ $0 | EDGAR |
| 2025-06-18 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 2,370 @ $0 | EDGAR |
| 2025-05-30 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 9,812 @ $0 | EDGAR |
| 2025-02-19 | 4 | EXELIXIS, INC. (EXEL) | Option exercise (M): 15,874 @ $20.50 · Option exercise (M): 28,240 @ $22.10 · Sale (S): 44,114 @ $34.94 · Option exercise (M): 15,874 (derivative) @ $0 · Option exercise (M): 28,240 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 2,032 @ $0 | EDGAR |
| 2024-08-16 | 4 | EXELIXIS, INC. (EXEL) | Sale (S): 8,250 @ $26.56 | EDGAR |
| 2024-06-25 | 4 | BIOGEN INC. (BIIB) | Grant/award (A): 1,340 @ $0 | EDGAR |
| 2024-06-04 | 4 | EXELIXIS, INC. (EXEL) | Grant/award (A): 18,838 @ $0 | EDGAR |
| 2024-01-17 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 1,585 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1547999 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →